In this study, we first performed the bioinformatic analysis on the pediatric and adult septic patient datasets to demonstrate the clinical significance of TLR4 and TLR2 inhibition as a promising therapeutic approach in treating sepsis. The gene discussed is TLR2; the disease is Sepsis.